Literature DB >> 27025610

Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion.

Gang Zhao1, Hongyi Zhang2, Ziming Huang3, Liping Lv4, Fan Yan4.   

Abstract

This study was aimed to evaluate the regulation mechanism of cortactin (CTTN) on matrix metalloproteinases 9 (MMP-9) and its relations with Exo70 in invasion of hepatoma carcinoma (HCC) cells. The expression levels of CTTN, Exo70 and MMP-9 were detected in normal hepatocytes and various HCC cells by real-time PCR. Then the migration and invasion ability of these cells was revealed by scratch and invasion assay. The effects of CTTN on MMP-9 and the ability of migration and invasion were evaluated by silence and overexpress CTTN. During this process, the expression of CTTN was detected by Western blot, the activity and concentration of MMP-9 in supernatant of culture medium was detected by zymography and ELISA assay. Besides, Exo70 was also inhibited to reveal its effects on MMP-9 and the migration and invasion ability of LM3. Increased expression of CTTN, MMP-9, Exo70, reduced scratch area and increased puncture cell numbers were found in HCC cells (p < 0.05). The expression of CTTN was significantly correlated with Exo70 and the migration and invasion ability of HCC (p < 0.05). In addition, the activity and concentration of MMP-9 were significantly affected by the expression level of CTTN, while the expression of MMP-9 was not influenced. Besides, Exo70-si also exhibited significantly inhibition effects on the activity and concentration of MMP-9 and puncture cell numbers (p < 0.05). A synergistic reaction may exhibited on CTTN and Exo70, which could mediate the secretion of MMPs thereby regulate tumor invasion.

Entities:  

Keywords:  Cortactin; Exo70; Hepatocellular carcinoma; Invasion; Matrix metalloproteinase 9

Mesh:

Substances:

Year:  2016        PMID: 27025610     DOI: 10.1007/s11033-016-3972-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  19 in total

Review 1.  Matrix metalloproteinases.

Authors:  O Zitka; J Kukacka; S Krizkova; D Huska; V Adam; M Masarik; R Prusa; R Kizek
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 2.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

Review 3.  Invadopodia: specialized cell structures for cancer invasion.

Authors:  Alissa M Weaver
Journal:  Clin Exp Metastasis       Date:  2006-07-09       Impact factor: 5.150

Review 4.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

5.  Exo70 interacts with the Arp2/3 complex and regulates cell migration.

Authors:  Xiaofeng Zuo; Jian Zhang; Ying Zhang; Shu-Chan Hsu; Daoguo Zhou; Wei Guo
Journal:  Nat Cell Biol       Date:  2006-11-05       Impact factor: 28.824

6.  Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.

Authors:  Emily S Clark; Amy S Whigham; Wendell G Yarbrough; Alissa M Weaver
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

7.  The role of the exocyst in matrix metalloproteinase secretion and actin dynamics during tumor cell invadopodia formation.

Authors:  Jianglan Liu; Peng Yue; Vira V Artym; Susette C Mueller; Wei Guo
Journal:  Mol Biol Cell       Date:  2009-06-17       Impact factor: 4.138

Review 8.  The exocyst complex in polarized exocytosis.

Authors:  Bing He; Wei Guo
Journal:  Curr Opin Cell Biol       Date:  2009-05-25       Impact factor: 8.382

9.  Sec6/8 complexes on trans-Golgi network and plasma membrane regulate late stages of exocytosis in mammalian cells.

Authors:  C Yeaman; K K Grindstaff; J R Wright; W J Nelson
Journal:  J Cell Biol       Date:  2001-11-05       Impact factor: 10.539

10.  Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK.

Authors:  Xiaoying Zhou; Guifang Xu; Chengqiang Yin; Wujuan Jin; Guoxin Zhang
Journal:  Oncotarget       Date:  2014-11-30
View more
  6 in total

1.  Tumor LXR Expression is a Prognostic Marker for Patients with Hepatocellular Carcinoma.

Authors:  Houyong Long; Xingjun Guo; Shen Qiao; Qingxing Huang
Journal:  Pathol Oncol Res       Date:  2017-05-16       Impact factor: 3.201

2.  Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure.

Authors:  Andras Iring; Young-June Jin; Julián Albarrán-Juárez; Mauro Siragusa; ShengPeng Wang; Péter T Dancs; Akiko Nakayama; Sarah Tonack; Min Chen; Carsten Künne; Anna M Sokol; Stefan Günther; Alfredo Martínez; Ingrid Fleming; Nina Wettschureck; Johannes Graumann; Lee S Weinstein; Stefan Offermanns
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

3.  Exo70 is an independent prognostic factor in colon cancer.

Authors:  Li Xiao; Kaifeng Zheng; Xia Lv; Jihuan Hou; Liang Xu; Yujie Zhao; Fei Song; Yaqiong Fan; Hanwei Cao; Wenqing Zhang; Xiaoting Hong; Yan-Yan Zhan; Tianhui Hu
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

4.  Cav2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization.

Authors:  Ying Xue; Min Li; Jie Hu; Yuanlin Song; Wei Guo; Changhong Miao; Di Ge; Yingyong Hou; Xuefei Wang; Xingxu Huang; Tianshu Liu; Xiaoping Zhang; Qihong Huang
Journal:  Cell Death Dis       Date:  2022-09-22       Impact factor: 9.685

Review 5.  Cortactin in cancer cell migration and invasion.

Authors:  Miao Yin; Wenqing Ma; Liguo An
Journal:  Oncotarget       Date:  2017-09-19

6.  XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.

Authors:  Jie Jian; Shuang Li; Li-Zhen Liu; Li Zhen; Ling Yao; Li-Hong Gan; Ya-Qing Huang; Nian Fang
Journal:  Int J Mol Med       Date:  2020-05-04       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.